These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2424251)

  • 21. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo. Relationship between C5a and proteins with the characteristics of IL-8/neutrophil-activating protein 1.
    Collins PD; Jose PJ; Williams TJ
    J Immunol; 1991 Jan; 146(2):677-84. PubMed ID: 1898960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
    Perez HD; Horn JK; Ong R; Goldstein IM
    J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of C5a antagonist by synovial and peritoneal tissue fibroblasts.
    Matzner Y; Gavison R; Shlomai Z; Ben-Bassat H; Liebergal M; Robinson DR; Babior BM
    J Cell Physiol; 1986 Nov; 129(2):215-20. PubMed ID: 3771654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
    Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
    Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of human C5a as a mediator of inflammation in normal human skin.
    Yancey KB; Hammer CH; Harvath L; Renfer L; Frank MM; Lawley TJ
    J Clin Invest; 1985 Feb; 75(2):486-95. PubMed ID: 2982914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils.
    Kew RR; Fisher JA; Webster RO
    J Immunol; 1995 Dec; 155(11):5369-74. PubMed ID: 7594552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A C5a inhibitor in peritoneal fluid.
    Matzner Y; Brzezinski A
    J Lab Clin Med; 1984 Feb; 103(2):227-35. PubMed ID: 6693795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
    Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
    Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.